Filing Details
- Accession Number:
- 0001140361-12-039425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-05 14:21:34
- Reporting Period:
- 2012-09-04
- Filing Date:
- 2012-09-05
- Accepted Time:
- 2012-09-05 14:21:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1362490 | Todd Zankel | C/O Raptor Pharmaceutical Corp. 9 Commercial Blvd., Suite 200 Novato CA 94949 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-04 | 842 | $5.00 | 651,866 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.